INCR
NASDAQ · Pharmaceuticals
Intercure Ltd
$5.31
+0.00 (+0.00%)
Open$5.35
Previous Close$5.31
Day High$5.35
Day Low$5.30
52W High$2,783.50
52W Low$253.30
Volume—
Avg Volume7.3K
Market Cap192.14M
P/E Ratio—
EPS$-6.28
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+652.4% upside
Current
$5.31
$5.31
Target
$39.95
$39.95
$34.56
$39.95 avg
$63.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 951.02M | 924.85M | 56.95M |
| Net Income | -121,357,062 | -106,215,458 | 10.61M |
| Profit Margin | -28.4% | -27.0% | 18.6% |
| EBITDA | -64,808,024 | -59,873,210 | 17.54M |
| Free Cash Flow | — | — | 14.62M |
| Rev Growth | +2.8% | +2.8% | -4.9% |
| Debt/Equity | 0.46 | 0.46 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |